Approximately 5% of FSHD patients have FSHD2, which is characterized by hypomethylation of the D4Z4 locus in combination with a permissive 4qA haplotype, but without a D4Z4 contraction (8–10). The gene discussed is SMCHD1; the disease is facioscapulohumeral muscular dystrophy.